pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-500b |
Genomic Coordinates | chrX: 50010672 - 50010750 |
Description | Homo sapiens miR-500b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-500b-3p | ||||||
Sequence | 51| GCACCCAGGCAAGGAUUCUG |70 | ||||||
Evidence | Experimental | ||||||
Experiments | Illumina | ||||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZFP14 | ||||||||||||||||||||
Synonyms | ZNF531 | ||||||||||||||||||||
Description | ZFP14 zinc finger protein | ||||||||||||||||||||
Transcript | NM_020917 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZFP14 | |||||||||||||||||||||
3'UTR of ZFP14 (miRNA target sites are highlighted) |
>ZFP14|NM_020917|3'UTR 1 TAGAAGAAAGCCTTCAAATGTATATGATGTTACAGAACATCAGAAAATTCATTTTTGAGAAAATGTGTTTCATGCTCAAT 81 TCCAAGCATAATAAATTTTATATTAGAGAAAGAATATGTTGATTTAAAAGCCTTCCAACACCATTTAAACATGGTTTATC 161 TTCAGCAAATTCCTATGAGAGAATAATGTAATGAATGTAGGAAAATCTTTAGCCTTATCTGTCATTATCTCCCTTTCTCC 241 ACTTGATTACCAGTTTGATTTATTGGACAAGATACTAAGCTTCTGTGCCTCATTTTGCTGACTTGTAAAATGGTAATAAT 321 AGTACTTATATGTATTAGTTATTTATTGCTGCGTAATAAATTACCACAGACTTAGTAGCATAAAATAACATATAATTATA 401 TCTTATAATTTGGATCAGGAGTATAGGCATGACTTAGTTGGGTCCTCTGCTTCAGGGTCTCTTGCAAGGCTACAGATTTC 481 AGCCAGGGCTGAGGTCTCATCTGAAGGCTCAACTGGGGAAGGATCCACATCCAGACTAACATAGTTGTTACCCAATGTAT 561 TTCCGTGAGGCCTGTTGCATTGAGATTCTCAGTTTCTAGCTGGCTGTTGGCTGAACGCTGACTGCAGCTCCTGGCCACAA 641 TAGCCTCATCAACATGGCTGCTTGCTTCATCAAGGCATGCAAGCCAAAAGGGAGGACAGTCTGCTAGCAAGATGGAAGTT 721 ACCATCTTGTGTAATCTAATCATGGAAGTAACATTCCCTCACCTTCTACTGGTAGAAGTAAGTTACTAGGATAGTCCACA 801 CTCAAGAGAACGGGATGATACAAGAGTGTGAATAAGTCCTGGAGACAGGACCACTGGGGGGCCTGTTTAGAGTCAGCCTG 881 CCACACTGTGGAATAGGATTGTTGCAAGGAGTAAGTAGTTAATACTTGGAGGAATCACAGTCATATAGCATGTATTCTGT 961 AAATATTATCTGTAATTGTTATTATTGTCATTAGTATTAGTGAATTCACGTAAAAGGAAGATCTGTAGACATAATAAATG 1041 TAGAAATGCCTCCTGTCACCTCTCAGAAATTATTAAACATAATTTATTCTAGGTAAAATTTAGATTGTAGTGAATGTAGG 1121 AAGTTCTTCAGCACTTGAGCTGCATTAGAAATTTCATGCCAAAAATGAATTTCATGAATGTGAGGTCACTAGTAATACAG 1201 CTGTTGAAGAATTAGAGGGAAATAGGAAATGATTTTCCCATAATTCCAGAAAGCAAAAGGCTTACAATCCCTGTTGTCTG 1281 ACCACAGTTTAAAATTAATTAGAAACTATCAAAAATGTGGCTTAAAAGAAATTAACCACCTAGGAATTTAATATTGTTGT 1361 GTATATTTATGTGTGTGTATAAAACTCCTGTGGGAAAGAAACAAAACATCATTCTATAAGTCAGTATACTTTTGGATGCT 1441 CAAAATGCCATATCTTCAACCAGTAGGAGTTGTTTCAAGTTGAGTTTTTGATGTGATCCCACCAATAATTTGATAGTTTA 1521 CTTGATTGTGGCTGCATAATTTGGTAACCTATGAAAGATGCTAGAGCACCAATGTATAATTTTTTTGAGACAGGGTGTCA 1601 CTTTGTCCCCCAGGCTGGAGTGCAGTGGTACAAGCACAGTTCACTGTACCCTGTTCCTCCTGGGCTCAAGTGATTCTTCC 1681 ACCTAAATTTTTTTTTTTTTTTTAGAGAAAGGGTCTCACTATGTTGCCCAGGCTGGTCTTGAACTTCTGGGCTCAAGTGA 1761 TCCTCCCTCCTTGGCCTCCAAAGGTGCTGGGGTTACAGGTATGAGCCACCACACCCAGCCCAACTCATTATTCTTGAAAT 1841 CAATAAATCAGAGGAAAAATTGTCATTTAGTTTCCTTTTCCCATGTGAACCAAATTTCAGGGTCACCAGAAGTTCATCAA 1921 ATTCAAATGAATTTGGCCTGGCACAGGGGTCACACCTGTAATCCCAGCACTTTGGGAGGACAAGGTGGGTGGATCACTTG 2001 AGGCCAGGAGTTTGAGACCAACCTGGTTAACATGGTGAAACCCTGTCTGTACTAAAAATACAAAATTTAGCCAGGCATGG 2081 TGGCACACACCTGTAGTCCCAGGCTGAGGTGGGAGGATCACTTGAACCCAAGAGGCAGAGTTTGCAGTGAGCTGAGATCG 2161 TGCCACTGCACTCCAGCCTGGGTGACAGAGTGAGACCCTGTCTCAAAAAAAAAATTTGTTTTTTGAATGGGTTTTTCTTT 2241 TTTGAAGAAGTCTAATAAATCTAGAAGGAATTAGAGGATTAGAAAAATCACCATTTTCTAGACCTTAATGGAATAATGGG 2321 TCCAGAAAACATGATCTTCAATGGGTACTACAACTAATAGGTGAAATATTTTATAGCGAGATTTTTATGGTGGATCTATC 2401 AAACTGGCCACCTCTGAACCCTTTGATCTGTTTTAACCTTAATAAAAATGGGTCTATCAGACAACACACTTCCTGACGTA 2481 ATGCAATAGGAAGTCCACACCACCATCTACAAAGCCTTATTGCTGGAATAATGAACTGAAAGCAGACAGGGACTAGATGA 2561 ACAGTATATGGTCATCCCTTGGTATCCATGGGGAATTGGTTCCAGGATCCTCCACTGATGGTAAAATCTGAGGATGCTCA 2641 AGTCCCTTGTATAAAATGGCATAGTATGTATTTGCATATTACCTACTCACATCTTCCTGTATACTTTAAATTATCTTTAG 2721 ATCACTTATACCTATCACAATGTAAATACTATGTAAATAGTTGTTATACTGTATTTTTCAATTTGCATTATTTTTATTGT 2801 ATTTTATTTTTATTGTTTTTTTTTGAGTATTTTCTATTTGAGATTGGTTGAATCTGCACATATGGAGGGCTGGCTATAAA 2881 GGGCACCACAAGGAAGAAGCCAAACAGATCCAGAATGTGTGAAATTCTACAGAGCAAATTACCTGATTTCTTCAACTAAC 2961 AGGTAGCATGAAAATACAAGGGGAAGGGCAACCATTAACAGATTAAAAGAGACTTAAAGAGACATATCAACTAAATTCAG 3041 TATGTTGGCATTACTTGGACCTGGTTTGAACAAAACATAAAAAGCCATTTTGGAGACAGTGAGGGAAGTGTGGACATGGA 3121 CTAAATATTAAATGATATTTACATATATTAATTTGGTTAGGGATTATGTCAGTGTGATTATAAAAAATAAAAGATCGTAT 3201 GATATGAGATACATACTATGAAATGAAGATAGACACATTTGGATTAAAATATTCTAGCAAAAGAAATAATTGGCAAAGAG 3281 AGCTGGAAACTAAATTGGCAACATGTTGATAATTTAAGTGGAGTGTTTTGTTCATGGAGACTTATTGTTCTAATATTTCT 3361 ACTTTTGTATGTGTTTGAAATTTCAATAATAAAATGTTTAAAATCAAAACCAAAATTATAGACTATGTAGAAATGAATGA 3441 CAGTGAGATGCCTGCACATCTAACCTTGTCAGATATAATCAAAGTTCTGTTCAGTGACAAATTAATGCCCTGTAATGTGG 3521 TAAGGAAATCTTATTTGTGGATACAGTCTTCATCTTCTTCACTTACCCACAGCAGCAACACCAGGCCTGTCACACAGATG 3601 AATGTGTTGAGGGAATGAATAAGTATTTCCGTCAAGAAAAAGGAAACAACAAAATAAAACCAACCCAAGTAAAGAACAGC 3681 CAAGTGGCCAGGTGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCATGGCAGGTGGATCACCTGAGGTCGGG 3761 ATTTTGAGACCAGCCTGACCAACACTGAGAAACCCCATCTCTATTAAAGATACAAAATTAGCCAGGCATGGTGGTGCATG 3841 CCTGTAATCCCAGCTACTTGGGAGGCTAAGGCAGGAGAATCACTTGAATCCAGGAGGCGGAGTTTGTGGTGAGTTGAGAT 3921 CGCGCCACTGCACTCCAGCCTGGGTAACAGAGCAAGAGTCTGTCAAAAAAAAAAAAAAAAAAAAAGGAACAGCCAAGTAA 4001 CAGTAGAAAGTAGAAATTAAGAGAATGGAGAATATTAGACTTGATTCAATGTTAATAGTGATTAGATTTTGGCAGTTATA 4081 ATCAAGGAAGAGAAAATGAAAGATAATACATTTAGAGTATTAATGATGATAAAAGAGACACAACTCTAGATTATATCAAG 4161 CAGATTTTTAAAATTATAAGGCAAAACTAGGCCGGGCACAGTGGCTCACACCTGTAACCCCAGCACTTTGGGAGGCCGAG 4241 GTGGGTGGATCACTTGAAGTCAGGAGTTCGAGACCAGCCTGACCAACATAGCAAAACCCCATCTCTACTAAAAATACAAA 4321 AATTAGCCTGTCATGGTGGCGGGCACCTGTAATCTAAGCTACTGGGGAGCCTGAGGCAGGAGAATTGCTTGAACCCAGGA 4401 GGCAGAGGTTGCGGTGAACCAAGATCACGCCACTGCACTCCAGCCTGGGTGACAGAGTGAGAACCTGTCTCAAAAATAAT 4481 AAACATAATATGGTAAAACTATACATGCACACATGCACAAACGTGTATATTCATTCCAGTACAAGTAAAAATGTAGGATT 4561 GCATTTTTCCCCCAAAAGGAATATGTTTTACAATTAACTCACCGTATAACCCAAATAGATTAACAAAAAATGTGTGTGTG 4641 TGTGTGTGTGTGTGAACTCCCTGTTTAAAAAATCTGATACTTATAAAAACTTTAAGGAATAGATAATCCTAAAGATTTTA 4721 CCAATTAATTCTGCAAGGTAAAATAATCCTAATAAAAATTAGATGAAGATAGTTTCTGAAAGCAAATTCTAGACCACCTT 4801 CATTATGAAGATTCTATTTTTCACAATTCTAAATAAAGTTTATTTAGAATTTATTACAAAATCTATCTTTGCTAATAGGT 4881 CAGTGTTTCTTTTCCCAAGCACCAAATACCTCCAGAAAGCCTGTGTTTGACCCCTAAATTCAACATTCTCCAGAAGTTTG 4961 CTTCAAGGAATATTAATTCTCGATGGTATTTGAAAAAAAGATTTCTTGGGAAAATAGGCAAATGAAGCAAAACATAAAAC 5041 ATCTACTTTTGGCCAGGCACGGTGGCTCACGCCTGTAATCCCAACATTTTGGGAGGCCAAGGCGAGCAGATCACTTGAGG 5121 TCAGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAATTAGCTGGGCGTGGTGGC 5201 TTGCACCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAAATGGAGATTGCAGTGAGCT 5281 GAGATTTTGCCATTGCACTCCAACCTGGGCAACAAGAGTGAAACTCAGTCTCAAATAAAATAAAATAAAAATCTACTTTT 5361 GAGGAATTCAAAGTATACATGATCAGTTTGCCAAAGATTTAGTAAAGACATTTTTATTTAACTGAGTGTATCTCAAATTT 5441 ATTGTGGAATTCTCAGTCCGAATATCTGGAATAGGAACAGCTTTGTTAGATGCTACCATAACCACAATGAATGTCTTCAA 5521 GGGTGTAATTTTAGATATGGTGAGTGGTTGTGTTGGGGGCGGCATAAGTCAGGGCAATTTTTTGCAGCTCATATCATGCT 5601 CTGAAAGTAGCTACCTGCTTTAATGGATGGTTAGTGCTTTTCTATAGAATGGAAAAGATTCCAGCCCGATCCTTGATATG 5681 TTTGTGTTAAACATGCTTATATATTATATTAAACAATGATTAAGGACATAAATGAGTTTCTGTGGTAATAAAGATGCTAT 5761 ATTGAATATCAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | BT474 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1395167. RNA binding protein: AGO. Condition:BT474 AGO HITS-CLIP Replicate 2
... - Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al., 2014, Breast cancer research and treatment. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al. - Breast cancer research and treatment, 2014
miRNAs regulate the expression of genes in both normal physiology and disease. While miRNAs have been demonstrated to play a pivotal role in aspects of cancer biology, these reports have generally focused on the regulation of single genes. Such single-gene approaches have significant limitations, relying on miRNA expression levels and heuristic predictions of mRNA-binding sites. This results in only circumstantial evidence of miRNA-target interaction and typically leads to large numbers of false positive predictions. Here, we used a genome-wide approach (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation, HITS-CLIP) to define direct miRNA-mRNA interactions in three breast cancer subtypes (estrogen receptor positive, Her2 amplified, and triple negative). Focusing on steroid receptor signaling, we identified two novel regulators of the ER pathway (miR-9-5p and miR-193a/b-3p), which together target multiple genes involved in ER signaling. Moreover, this approach enabled the definition of miR-9-5p as a global regulator of steroid receptor signaling in breast cancer. We show that miRNA targets and networks defined by HITS-CLIP under physiologic conditions are predictive of patient outcomes and provide global insight into miRNA regulation in breast cancer.
LinkOut: [PMID: 24906430]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cardiac Tissues |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202479. RNA binding protein: AGO2. Condition:S4_LV_29yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM1395167 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | BT474 / BT474 AGO HITS-CLIP Replicate 2 |
Location of target site | ENST00000270001.7 | 3UTR | UUGCGGUGAACCAAGAUCACGCCACUGCACUCCAGCCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24906430 / GSE57855 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
172 hsa-miR-500b-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT059905 | HDGF | heparin binding growth factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT235394 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT442246 | PYGO1 | pygopus family PHD finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443591 | ZNF439 | zinc finger protein 439 | ![]() |
![]() |
2 | 4 | ||||||
MIRT453280 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463540 | ZBTB7A | zinc finger and BTB domain containing 7A | ![]() |
![]() |
2 | 2 | ||||||
MIRT465589 | TNRC6B | trinucleotide repeat containing 6B | ![]() |
![]() |
2 | 2 | ||||||
MIRT469462 | REL | REL proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT485449 | KCTD15 | potassium channel tetramerization domain containing 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT486682 | WDR81 | WD repeat domain 81 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489078 | POLM | DNA polymerase mu | ![]() |
![]() |
2 | 2 | ||||||
MIRT493734 | GREM2 | gremlin 2, DAN family BMP antagonist | ![]() |
![]() |
2 | 2 | ||||||
MIRT494872 | DYNLL2 | dynein light chain LC8-type 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496130 | RNF103-CHMP3 | RNF103-CHMP3 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT496489 | CHMP3 | charged multivesicular body protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496924 | CLMN | calmin | ![]() |
![]() |
2 | 2 | ||||||
MIRT497297 | TMEM119 | transmembrane protein 119 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499103 | AGRN | agrin | ![]() |
![]() |
2 | 2 | ||||||
MIRT508979 | CXorf38 | chromosome X open reading frame 38 | ![]() |
![]() |
2 | 2 | ||||||
MIRT509911 | NIPAL1 | NIPA like domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT512820 | ARRDC2 | arrestin domain containing 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512827 | KBTBD6 | kelch repeat and BTB domain containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT515360 | MRPL52 | mitochondrial ribosomal protein L52 | ![]() |
![]() |
2 | 2 | ||||||
MIRT516610 | TRIM58 | tripartite motif containing 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517053 | TLDC1 | TBC/LysM-associated domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517637 | ZNF491 | zinc finger protein 491 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518270 | LEAP2 | liver enriched antimicrobial peptide 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518625 | STAR | steroidogenic acute regulatory protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT518887 | N4BP2L2 | NEDD4 binding protein 2 like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519026 | PAICS | phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase | ![]() |
![]() |
2 | 2 | ||||||
MIRT520365 | UBE2G2 | ubiquitin conjugating enzyme E2 G2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521106 | SLC1A5 | solute carrier family 1 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521943 | PHC3 | polyhomeotic homolog 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522253 | NPEPPS | aminopeptidase puromycin sensitive | ![]() |
![]() |
2 | 2 | ||||||
MIRT522853 | KIAA1551 | KIAA1551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522868 | KIAA1549 | KIAA1549 | ![]() |
![]() |
2 | 2 | ||||||
MIRT524207 | DDX19B | DEAD-box helicase 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT526004 | ARHGAP27 | Rho GTPase activating protein 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527769 | RRAD | RRAD, Ras related glycolysis inhibitor and calcium channel regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT527827 | TMEM74B | transmembrane protein 74B | ![]() |
![]() |
2 | 2 | ||||||
MIRT527861 | SMOC1 | SPARC related modular calcium binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528040 | WT1 | Wilms tumor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529802 | ZDHHC8 | zinc finger DHHC-type containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531723 | TARS | threonyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT531996 | BARD1 | BRCA1 associated RING domain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533338 | UNC119B | unc-119 lipid binding chaperone B | ![]() |
![]() |
2 | 2 | ||||||
MIRT533621 | TNFRSF13C | TNF receptor superfamily member 13C | ![]() |
![]() |
2 | 2 | ||||||
MIRT533652 | TMOD2 | tropomodulin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534397 | SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538686 | CCDC80 | coiled-coil domain containing 80 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540444 | RBM43 | RNA binding motif protein 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542586 | ZC3H12C | zinc finger CCCH-type containing 12C | ![]() |
![]() |
2 | 8 | ||||||
MIRT542796 | PLEKHA3 | pleckstrin homology domain containing A3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT542991 | ERC1 | ELKS/RAB6-interacting/CAST family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544424 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 4 | ||||||
MIRT545740 | ESF1 | ESF1 nucleolar pre-rRNA processing protein homolog | ![]() |
![]() |
2 | 4 | ||||||
MIRT552618 | ZBTB8A | zinc finger and BTB domain containing 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT554456 | SAMD8 | sterile alpha motif domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569663 | PRIM1 | DNA primase subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569924 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570140 | IL1RL2 | interleukin 1 receptor like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573558 | TMEM120B | transmembrane protein 120B | ![]() |
![]() |
2 | 2 | ||||||
MIRT574282 | OPRD1 | opioid receptor delta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575335 | Fbxo6 | F-box protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607057 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT607078 | POM121L7 | POM121 transmembrane nucleoporin like 7 pseudogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT607500 | HEBP2 | heme binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607530 | ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT607808 | RHBDL2 | rhomboid like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608079 | ZFP14 | ZFP14 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT609119 | NUDT3 | nudix hydrolase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609745 | PTCH1 | patched 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT612904 | HIF1AN | hypoxia inducible factor 1 alpha subunit inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT618720 | PCSK2 | proprotein convertase subtilisin/kexin type 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618778 | HLA-E | major histocompatibility complex, class I, E | ![]() |
![]() |
2 | 2 | ||||||
MIRT619015 | SLC2A6 | solute carrier family 2 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623223 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | ![]() |
![]() |
2 | 2 | ||||||
MIRT623819 | GEMIN6 | gem nuclear organelle associated protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625704 | OPTN | optineurin | ![]() |
![]() |
2 | 2 | ||||||
MIRT626437 | CHDH | choline dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT628087 | KAT7 | lysine acetyltransferase 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628936 | APOB | apolipoprotein B | ![]() |
![]() |
2 | 2 | ||||||
MIRT633543 | PGBD5 | piggyBac transposable element derived 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634348 | SGOL1 | shugoshin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634611 | KIAA1919 | major facilitator superfamily domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT635243 | QPRT | quinolinate phosphoribosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT636681 | BTLA | B and T lymphocyte associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT636923 | ZNF845 | zinc finger protein 845 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637606 | ZNF554 | zinc finger protein 554 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639242 | RANGAP1 | Ran GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640835 | POLR3A | RNA polymerase III subunit A | ![]() |
![]() |
2 | 2 | ||||||
MIRT642098 | FBXL2 | F-box and leucine rich repeat protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643087 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | ![]() |
1 | 1 | |||||||
MIRT643934 | C17orf104 | meiosis specific with coiled-coil domain | ![]() |
![]() |
2 | 2 | ||||||
MIRT644353 | FXN | frataxin | ![]() |
![]() |
2 | 2 | ||||||
MIRT645628 | SF3A3 | splicing factor 3a subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645754 | FAM213A | family with sequence similarity 213 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT646329 | MVB12B | multivesicular body subunit 12B | ![]() |
![]() |
2 | 2 | ||||||
MIRT646817 | COX19 | COX19, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT647019 | ADCY2 | adenylate cyclase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647621 | IGSF9B | immunoglobulin superfamily member 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT648517 | PIGG | phosphatidylinositol glycan anchor biosynthesis class G | ![]() |
![]() |
2 | 2 | ||||||
MIRT648871 | ABCA6 | ATP binding cassette subfamily A member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649620 | ITPKC | inositol-trisphosphate 3-kinase C | ![]() |
![]() |
2 | 2 | ||||||
MIRT650062 | CCDC134 | coiled-coil domain containing 134 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650734 | TNFSF8 | TNF superfamily member 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652389 | TMEM55A | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654352 | RBM27 | RNA binding motif protein 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655796 | NOVA2 | NOVA alternative splicing regulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657329 | HNRNPK | heterogeneous nuclear ribonucleoprotein K | ![]() |
![]() |
2 | 2 | ||||||
MIRT657734 | GOSR1 | golgi SNAP receptor complex member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660613 | ANO6 | anoctamin 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661243 | ARL17B | ADP ribosylation factor like GTPase 17B | ![]() |
![]() |
2 | 2 | ||||||
MIRT662245 | PGBD4 | piggyBac transposable element derived 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662921 | MED18 | mediator complex subunit 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662963 | JPH2 | junctophilin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663347 | ZNF74 | zinc finger protein 74 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663528 | MASTL | microtubule associated serine/threonine kinase like | ![]() |
![]() |
2 | 2 | ||||||
MIRT663547 | CCR6 | C-C motif chemokine receptor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663977 | ZNF786 | zinc finger protein 786 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664084 | METTL2B | methyltransferase like 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT664358 | C16orf45 | chromosome 16 open reading frame 45 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664421 | TIGD6 | tigger transposable element derived 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664476 | ZYG11B | zyg-11 family member B, cell cycle regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT664979 | TDRD1 | tudor domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665128 | PYCRL | pyrroline-5-carboxylate reductase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666259 | SLC31A1 | solute carrier family 31 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666321 | SLC16A10 | solute carrier family 16 member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666881 | POLQ | DNA polymerase theta | ![]() |
![]() |
2 | 2 | ||||||
MIRT668469 | FADS6 | fatty acid desaturase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669554 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT669835 | ISCA2 | iron-sulfur cluster assembly 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT670185 | CCDC142 | coiled-coil domain containing 142 | ![]() |
![]() |
2 | 2 | ||||||
MIRT672020 | PXMP4 | peroxisomal membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT672070 | KIAA0930 | KIAA0930 | ![]() |
![]() |
2 | 2 | ||||||
MIRT672475 | RTTN | rotatin | ![]() |
![]() |
2 | 2 | ||||||
MIRT672851 | ICOSLG | inducible T-cell costimulator ligand | ![]() |
![]() |
2 | 2 | ||||||
MIRT673090 | AK1 | adenylate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT673581 | KDELC2 | KDEL motif containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674586 | SLC35B4 | solute carrier family 35 member B4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675001 | STRN3 | striatin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679018 | MTMR10 | myotubularin related protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679680 | STAT3 | signal transducer and activator of transcription 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682833 | FLG2 | filaggrin family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682886 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT683442 | AP3B2 | adaptor related protein complex 3 beta 2 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT687040 | RNF115 | ring finger protein 115 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691957 | RHOH | ras homolog family member H | ![]() |
![]() |
2 | 2 | ||||||
MIRT694625 | ZFPM1 | zinc finger protein, FOG family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695637 | SLC26A2 | solute carrier family 26 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697640 | WRN | Werner syndrome RecQ like helicase | ![]() |
![]() |
2 | 2 | ||||||
MIRT702009 | MIDN | midnolin | ![]() |
![]() |
2 | 2 | ||||||
MIRT702034 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT704789 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705728 | AMMECR1L | AMMECR1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT705879 | ADM | adrenomedullin | ![]() |
![]() |
2 | 2 | ||||||
MIRT706220 | ACOT9 | acyl-CoA thioesterase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708418 | CERS4 | ceramide synthase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709114 | C3orf18 | chromosome 3 open reading frame 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709595 | ITPA | inosine triphosphatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT710945 | MRPL45 | mitochondrial ribosomal protein L45 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712345 | NLN | neurolysin | ![]() |
![]() |
2 | 2 | ||||||
MIRT712530 | CYTH2 | cytohesin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714019 | ASCC1 | activating signal cointegrator 1 complex subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717287 | ARMC12 | armadillo repeat containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717733 | FGF1 | fibroblast growth factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718083 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718562 | MUC20 | mucin 20, cell surface associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT721639 | MYLK3 | myosin light chain kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722632 | C8A | complement C8 alpha chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT723177 | CDCA4 | cell division cycle associated 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725523 | FAM229B | family with sequence similarity 229 member B | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|